Shield Therapeutics PLC (LSE:STX) - Share price - Overview

Stock Report

Shield Therapeutics PLC STX

Last Price
GBX36.50

Day Change
0.00|0.00%

As of 22/06/2018
08:21:11 BST | GBX
Minimum 15 Minutes Delay.

Last Close36.50p
Day Range36.05 - 36.35
Mkt Cap42.50Mil
52-Wk Range14.00 - 160.00
Yield %-
ISINGB00BYV81293
Volume1,775
P/E-2.15
P/S0.64
P/CF-0.03

Share Price

Total Returns 22/06/2018

 Chg (%)  
More ...
Shield Therapeutics PLC28.07 
FTSE 100 TR GBP-2.14
 
Financials
201520162017
More ...
Income Statement
Turnover0.000.300.64
Operating Profit-6.43-12.46-20.95
Net Profit-24.49-15.02-19.59
Reported EPS-22.00-15.00-17.00
Balance Sheet
Current Assets2.3323.3815.00
Non Current Assets0.5329.0029.97
Total Assets2.8652.3844.97
Current Liabilities3.583.993.76
Total Liabilities21.503.993.76
Total Equity-18.6448.4041.21
Cash Flow
Operating Cash Flow-4.18-10.26-18.14
Net Change in Cash0.2520.25-7.68
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/10/2017Exercise of OptionMr. Carl Andrew Sterritt100.008,8148,814.00
05/07/2017PurchaseDr. Andrew John William Heath150.003,3345,001.00
28/06/2017PurchaseJoanne Elizabeth Estell150.0020,00030,000.00
28/06/2017PurchaseMr. Peter Hermann William Llewellyn-Davies150.0010,00015,000.00

Company Profile

Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.

Sector

Drug Manufacturers - Specialty & Generic

Index

Next Event 27/06/2018

Annual General Meeting
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-50.84
Op Mrgn-32.89
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr. Carl Andrew Sterritt
Non-Executive DirectorMr. Peter Hermann William Llewellyn-Davies
Non-Executive Director, ChairmanDr. Andrew John William Heath
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.